Abstract
The progress in genome-scale approaches to human diseases will soon require to understand the function of a large number of genes as potentially interesting therapeutic targets. The determination of their biological role needs to be accelerated in order to select valid therapeutic targets and streamline the drug discovery process. The sequencing of the human genome, as well as a number of model organisms, provides a strong framework to achieve this goal. Several methods among which gene expression profiling and protein interaction mapping are being used on a large-scale basis and constitute useful entry points to identify pathways involved in disease mechanisms. The resulting information is however limited. Other methods rely on the genetic manipulation of well-characterized and simple model organisms (SMOs) to reconstruct human disease-associated pathways and pinpoint biologically-valid therapeutic targets on the basis of function-based datasets generated in vivo. SMOs are strongly complementary to well-established complex mammalian models, and multiple ways exist to integrate SMOs into the early stage of the drug discovery process. In this review, we attempt to highlight some of the general criteria and essential methodological components associated with the use of SMO technologies for rapid functional genomics. Examples are provided to illustrate the utility of C. elegans and Drososphila for the validation of targets for central nervous system drugs.
Keywords: Therapeutic Targets, Simple model organisms SMOs, ESTs, CDNAs, Protein, EST expression Profiles, Biallelic Single uncleotide markers, DNA array, Proteomics, Target Validation
Current Genomics
Title: Defining Therapeutic Targets in Simple Model Organisms
Volume: 1 Issue: 2
Author(s): F. Thomas and C. Neri
Affiliation:
Keywords: Therapeutic Targets, Simple model organisms SMOs, ESTs, CDNAs, Protein, EST expression Profiles, Biallelic Single uncleotide markers, DNA array, Proteomics, Target Validation
Abstract: The progress in genome-scale approaches to human diseases will soon require to understand the function of a large number of genes as potentially interesting therapeutic targets. The determination of their biological role needs to be accelerated in order to select valid therapeutic targets and streamline the drug discovery process. The sequencing of the human genome, as well as a number of model organisms, provides a strong framework to achieve this goal. Several methods among which gene expression profiling and protein interaction mapping are being used on a large-scale basis and constitute useful entry points to identify pathways involved in disease mechanisms. The resulting information is however limited. Other methods rely on the genetic manipulation of well-characterized and simple model organisms (SMOs) to reconstruct human disease-associated pathways and pinpoint biologically-valid therapeutic targets on the basis of function-based datasets generated in vivo. SMOs are strongly complementary to well-established complex mammalian models, and multiple ways exist to integrate SMOs into the early stage of the drug discovery process. In this review, we attempt to highlight some of the general criteria and essential methodological components associated with the use of SMO technologies for rapid functional genomics. Examples are provided to illustrate the utility of C. elegans and Drososphila for the validation of targets for central nervous system drugs.
Export Options
About this article
Cite this article as:
Thomas F. and Neri C., Defining Therapeutic Targets in Simple Model Organisms, Current Genomics 2000; 1 (2) . https://dx.doi.org/10.2174/1389202003351544
DOI https://dx.doi.org/10.2174/1389202003351544 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vitro Evidence for Competitive TSPO Binding of the Imaging Biomarker Candidates Vinpocetine and Two Iodinated DAA1106 Analogues in Post Mortem Autoradiography Experiments on Whole Hemisphere Human Brain Slices
Current Radiopharmaceuticals Editorial (Thematic Issue: Immunotherapy in Central Nervous System)
Current Pharmaceutical Biotechnology Roles of miRNA in the Initiation and Development of Colorectal Carcinoma
Current Pharmaceutical Design The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms
Current Neuropharmacology Soft Bipolar Spectrum and Staging in Bipolar Disorder
Current Psychiatry Reviews Synthesis of Spiro Compounds Based on 1H-Pyrrole-2,3-Diones
Mini-Reviews in Organic Chemistry Cholinesterase Inhibitors Modulate Autonomic Function in Patients with Alzheimer´s Disease and Mixed Dementia
Current Alzheimer Research Chemical Intolerance
Current Rheumatology Reviews Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Computational and In-Vitro Validation of Natural Molecules as Potential Acetylcholinesterase Inhibitors and Neuroprotective Agents
Current Alzheimer Research Dense Gas Technology and Cyclodextrins: State of the Art and Potential
Current Organic Chemistry 21-Hydroxy-6,19-epoxyprogesterone: A Promising Therapeutic Agent and a Molecular Tool for Deciphering Glucocorticoid Action
Mini-Reviews in Medicinal Chemistry Modeling of Drug Released from Acyclovir Nanoparticles Based on Artificial Neural Networks
Letters in Drug Design & Discovery Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma
Anti-Cancer Agents in Medicinal Chemistry The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
Current Neuropharmacology Targeting Pathological Amyloid Aggregates with Conformation-Sensitive Antibodies
Current Alzheimer Research RAN GTPase as a Target for Cancer Therapy: Ran Binding Proteins
Current Molecular Medicine Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design Effect of Nicotine on ATPase, Catalase and Calcium Levels in the Presence of Oligoelements in Brain Regions of Young Rats
Cardiovascular & Hematological Disorders-Drug Targets Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case
Current Psychiatry Reviews